Skip to main content

This job has expired

You will need to login before you can apply for a job.

Manager, External Manufacturing

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Jan 27, 2021

View more

Discipline
Manufacturing & Production, Manufacturing/Mechanical
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

Intellia is growing! We are seeking a Manager of External Manufacturing manage relationships with key Contract Manufacturing Organizations (CMOs). In this newly created role, you will build and lead cross-functional teams to ensure delivery of program milestones. The successful candidate will help build the External Manufacturing function at Intellia by implementing phase-appropriate tools and best practices.

Responsibilities:
  • Serve as the primary contact and relationship manager to assigned CMOs; responsibilities include managing contract setup and negotiation, budget establishment and adherence, production planning, operational execution and on time and in full delivery of program deliverables
  • Lead cross-functional External Manufacturing Teams with membership from Process Development, Analytical Development, Quality, Regulatory, CMC Project Management, Supply Chain, Procurement and Finance; manage Team priorities at the CMO based on Intellia's needs across programs
  • Monitor CMO performance using a set of standard KPIs and report progress to management by leading Quarterly Business Reviews with the External Manufacturing Team
  • Identify and escalate business critical risks impacting supply and/or timelines with related mitigations and/or possible solutions
  • Contribute to the authoring of regulatory submissions
  • Create area Standard Operating Procedures (SOPs) as required


Qualifications:
  • Bachelor's Degree in Life Sciences, Engineering, Business, Supply Chain or related area
  • At least 8 years' experience in the biotechnology/pharmaceutical industry with a minimum of 2 years of experience in a GMP manufacturing environment
  • Demonstrated project and team leadership skills
  • Experience with cell and gene therapy manufacturing preferred
  • Ability to act in a complex and rapidly changing business environment


EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert